Clinical Trial Update: A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea. [Phase 3]

View source ↗

Summary

A Phase 3 randomized, double-blind study evaluated the safety, efficacy and tolerability of oral DFD-29 capsules for papulopustular rosacea; the trial has been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Papulopustular Rosacea

Drugs mentioned

• DFD-29 capsules (DFD-29)

Snippet

Sponsor: Journey Medical Corporation | Conditions: Papulopustular Rosacea | Phase 3 | Status: COMPLETED | Results posted: 2024-12-03